[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
February 28, 2007

Estimating the Population Prevalence of HPV

Author Affiliations
 

Author Affiliations: Department of Preventive Medicine and Community Health (Dr Weller), and Department of Pediatrics (Dr Stanberry), Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston.

JAMA. 2007;297(8):876-878. doi:10.1001/jama.297.8.876

Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, and HPV infection is associated with genital warts (HPV types 6 and 11) and cervical cancer (HPV types 16 and 18).1 In June 2006, the US Food and Drug Administration approved a vaccine against HPV types 6, 11, 16, and 18, and it is recommended for use in girls 11 and 12 years old.2

First Page Preview View Large
First page PDF preview
First page PDF preview
×